<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nearly one-half of persons with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> have <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> accounted for 44 percent of new cases of <z:mp ids='MP_0003606'>kidney failure</z:mp> in 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>Diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, also called <z:e sem="disease" ids="C0011881" disease_type="Disease or Syndrome" abbrv="">diabetic kidney disease</z:e>, is associated with significant macrovascular risk, and is the leading cause of <z:mp ids='MP_0003606'>kidney failure</z:mp> in the United States </plain></SENT>
<SENT sid="3" pm="."><plain>Diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> usually manifests after 10 years' duration of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, but may be present at diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Screening for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> should be initiated five years after diagnosis of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and at diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Screening for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> with a spot urine albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio identifies the early stages of <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Positive results on two of three tests (30 to 300 mg of albumin per g of <z:chebi fb="0" ids="16737">creatinine</z:chebi>) in a six-month period meet the diagnostic criteria for diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Because diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> may also manifest as a decreased glomerular filtration rate or an <z:hpo ids='HP_0003259'>increased serum creatinine</z:hpo> level, these tests should be included in annual monitoring </plain></SENT>
<SENT sid="8" pm="."><plain>Preventive measures include using an <z:chebi fb="0" ids="35457">angiotensin- converting enzyme inhibitor</z:chebi> or <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> receptor blocker in normotensive persons </plain></SENT>
<SENT sid="9" pm="."><plain>Optimizing glycemic control and using an <z:chebi fb="0" ids="35457">angiotensin-converting enzyme inhibitor</z:chebi> or <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> receptor blocker to control blood pressure slow the progression of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, but implementing intensive glycemic and blood pressure control is associated with more adverse outcomes </plain></SENT>
<SENT sid="10" pm="."><plain>Low-protein diets may also decrease adverse renal outcomes and mortality in persons with diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
</text></document>